New York-based hedge fund Jane Street has been granted permission by SEBI to resume trading in India, but with strict limitations. According to a Reuters report citing unnamed sources, the firm will not be allowed to trade in options, and it has voluntarily decided not to trade in cash until it provides further explanations to the market regulator.
“While the firm has been allowed to resume trading in India, it has given an undertaking to SEBI that it will not trade in options,” a source told Reuters.
Additionally, Jane Street has informed SEBI it will abstain from cash market trades until the matter is clarified.
SEBI had earlier issued an interim order suspending Jane Street’s market access, citing manipulation in the Indian market. However, the regulator recently sent an email to the firm on July 18, stating that the restrictions are no longer applicable following the deposit of impounded funds.
Despite the permission to trade again, the return is expected to be subdued, given the limitations on trading options and voluntary pause in the cash segment.
Read Also: New Leaders, New Gains: CEO Transitions Fuel Stock Market Surge in India Inc
Jane Street was accused of manipulating Indian indices through simultaneous bets in the cash, futures, and options markets between January 2023 and May 2025. SEBI alleged that the firm’s coordinated trades led to unfair profits, prompting a crackdown.
Total net gains reported during the probe period stood at ₹36,671 crore.
SEBI impounded over ₹4,843 crore, and suspended Jane Street’s market access earlier this month.
Though SEBI has lifted the restrictions, sources noted that the two Indian exchanges have not yet facilitated the firm’s buying and selling of securities. The process could take additional time as regulatory procedures are followed.
Rupee Extends Slide to Fresh All-Time Low as Trade Tensions and Importer Demand Intensify The…
Sensex Climbs 450 Points, Nifty Ends Near 26,050 as Global Cues Lift Market Sentiment Index…
Edelweiss Mutual Fund Announces First International Retail Offering Through GIFT City Platform Edelweiss Mutual Fund…
Cabinet Meets to Consider Major Policy Overhaul Including Census 2027 and Key Sectoral Reforms The…
Novo Nordisk Brings Ozempic to India at Competitive Weekly Price to Expand Diabetes Treatment Access…
ICICI Prudential AMC IPO GMP Rises as Investor Interest Builds Through the Session The grey…
This website uses cookies.